Interactions of IGF-1 with the blood-brain barrier in vivo and in situ

Neuroendocrinology

Volumn 72, Issue 3, 2000, Pages 171-178

  Pan, Weihong ^a,b   Kastin, Abba J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Amyotrophic lateral sclerosis; Blood brain barrier; Encephalomyelitis; Insulin like growth factors; Neuroregeneration; Spinal cord

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN C DERIVATIVE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN PERFUSION; CERVICAL SPINAL CORD; CONTROLLED STUDY; ENCEPHALOMYELITIS; HALF LIFE TIME; HORMONE ACTION; ISOTOPE LABELING; LUMBAR SPINAL CORD; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; REGRESSION ANALYSIS; THORACIC SPINAL CORD;

EID: 0033755363     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054584     Document Type: Article

References (25)

1. Opposite direction of transport across the blood-brain barrier for Tyr-MIF-1 and MIF-1: Comparison with morphine
2. Passage of peptides across the blood-brain barrier: Pathophysiological perspectives
3. Insulin-like growth factor binding proteins in the human circulation. A review
4. Rediscovering an old friend IGF-1: Potential use in the treatment of neurodegenerative diseases
5. Human blood-brain barrier insulin-like growth factor receptor
6. (des (1-3)IGF-I) relative to IGF-1 in lit/lit mice
7. The effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate, in different regions following hypoxic-ischemic brain injury in adult rats
8. Distribution of circulating insulin-like growth factor-I (IGF-I) into tissues
9. Effect of recombinant human insulin-like growth factor-I on progression of ALS
10. Hepatic production intestinal uptake of IGF-1: Response to infection
11. Insulin-like growth factor-I: Potential for treatment of motor neuronal disorders
12. Bioavailability of insulin-like growth factors (IGFs) in rats determined by the molecular distribution of human IGF-binding protein-3
13. Chronic relapsing experimental autoimmune encephalomyelitis: Effects of insulin-like growth factor-1 treatment on clinical deficits, lesion severity, glial responses and blood-brain barrier defects
14. Induction of IGF-1 mRNA expression following traumatic injury to the postnatal brain
15. Insulin-like growth factor 1 treatment reduces clinical deficits and lesion severity in acute demyelinating experimental autoimmune encephalomyelitis
16. Regulation of experimental autoimmune encephalomyelitis with insulin-like growth factor (IGF-1) and IGF-1/IGF-binding protein-3 complex (IGF-1/IGFBP3)
17. BBB permeability to ebiratide and TNF in acute spinal cord injury
18. Permeability of the blood-brain/spinal cord barrier to neurotrophins
19. Penetration of neurotrophins and cytokines across the blood-brain/blood-spinal cord barrier
20. Saturable entry of ciliary neurotrophic factor into brain
21. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data
22. Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF
23. Insulin-like growth factors cross the blood-brain barrier
24. Demonstration and structural comparison of receptors for insulin-like growth factor-I and -II (IGF-I and -II) in brain and blood-brain barrier
25. Potential utility of rhIGF-1 in neuromuscular and/or degenerative disease